Introduction {#section5-2050312117745223}
============

Non-alcoholic fatty liver disease (NAFLD) is characterized by accumulation of fat (steatosis) within liver cells due to causes other than alcohol.^[@bibr1-2050312117745223]^ NAFLD is the most common chronic liver disease which includes a wide range of medical conditions from simple steatosis to hepatic fibrosis and hepatocellular carcinoma (HCC).^[@bibr2-2050312117745223],[@bibr3-2050312117745223]^ Some risk factors have been proved to have a relationship with NAFLD. Obesity, based on the measure of body mass index (BMI), is an important risk factor for the pathogenesis and progression of NAFLD. However, some factors like lifestyle correction and regular caffeine consumption can decrease fibrosis of liver in patient with NAFLD.^[@bibr4-2050312117745223]^ The prevalence of NAFLD shows a 4.6-fold increase among obese individuals.^[@bibr5-2050312117745223]^ Other risk factors associated with NAFLD are waist circumference (more than 102 and 88 cm for males and females, respectively), hyperinsulinemia, hypertriglyceridemia, impaired glucose tolerance or type 2 diabetes, and smoking.^[@bibr6-2050312117745223][@bibr7-2050312117745223][@bibr8-2050312117745223]--[@bibr9-2050312117745223]^

According to a study in 2017, the prevalence of daily smoking in men and women are 25.0% and 5.4%, respectively. In 2015, smoking was the cause of death in 6.4 million (11.5%) of people.^[@bibr10-2050312117745223]^ In Europe, where approximately half of the adult males are regular smokers, the prevalence varies from 63% in Russia to 17% in Sweden.^[@bibr11-2050312117745223]^ In women, the pattern of the prevalence of tobacco smoking is different and the prevalence of smoking in developed countries and developing countries for women are 24% and 7%, respectively. In the last decade, smoking has become more common in many countries.^[@bibr10-2050312117745223]^

Tobacco smoking is one of the major risk factors for chronic diseases such as cardiovascular disease, cancer, and type 2 diabetes. Several studies show that smoking is also associated with liver diseases such as neoplasm of liver and chronic liver disease.^[@bibr12-2050312117745223][@bibr13-2050312117745223]--[@bibr14-2050312117745223]^ Basic and clinical research indicates that smoking affects some of the physiological pathways in the liver.^[@bibr15-2050312117745223][@bibr16-2050312117745223][@bibr17-2050312117745223]--[@bibr18-2050312117745223]^ Some studies on both humans and rats indicate that smoking has an association with the progression of NAFLD. However, the clinical correlation of these findings has been controversial. A cross-sectional study reported that active smoking was related to fibrosis in patients with NAFLD, while another study expresses a lack of significant relationships between active smoking and NAFLD.^[@bibr19-2050312117745223],[@bibr20-2050312117745223]^

Regarding this controversy, no systematic review and meta-analysis of the literature were found demonstrating an "association between smoking and NAFLD." Furthermore, because of the high prevalence of smoking in different populations and the importance of NAFLD in the progression of chronic liver disease, this study was designed in order to determine the association between smoking and NAFLD. Also, in this study, an effort was made to investigate the association between current, former, and passive smoking and NAFLD in observational studies.

Methods {#section6-2050312117745223}
=======

Literature search {#section7-2050312117745223}
-----------------

Electronic databases (Scopus, PubMed, and ISI Web of Science) were searched (until June 2016) by two independent investigators (B.H. and M.G.N.) for studies that provided information on the relationship between NAFLD and smoking in English literature. We improved our search strategy by hand-searching the reference lists of included papers to identify additional relevant studies.

Our search terms included variations of the concept of smoking (smoking, tobacco smoking, hookah smoking, water pipe smoking, pipe smoking, tobacco smoke pollution, environmental tobacco smoke pollution, passive smoking, secondhand smoking, involuntary smoking, cigarette smoking, and cigar smoking) and "fatty liver" concepts (fatty liver, steatohepatitis, steatohepatitides, steatosis of liver, visceral steatosis, visceral steatoses, liver steatosis, liver steatoses, NAFLD, non-alcoholic steatohepatitis (NASH), toxicant-associated steatohepatitis (TASH), and toxicant-associated fatty liver disease (TAFLD)). The strategy of search in ISI Web of Science is "(TS = (fatty liver) OR TS = (Steatohepatitis) OR TS = (Steatohepatitides) OR TS = (Steatosis of Liver) OR TS = (Visceral Steatosis) OR TS = (Visceral Steatoses) OR TS = (Liver Steatosis) OR TS = (Liver Steatoses) OR TS = (NAFLD) OR TS = (NAFLD) OR TS = (NASH) OR TS = (NASH) OR TS = (TASH) OR TS = (TAFLD)) AND (TS = (smoking) OR TS = (Tobacco Smoking) OR TS = (Hookah Smoking) OR TS = (Waterpipe Smoking) OR TS = (Pipe Smoking) OR TS = (Tobacco Smoke Pollutions) OR TS = (Environmental Tobacco Smoke Pollution) OR TS = (Passive Smokings) OR TS = (Secondhand Smoking) OR TS = (Involuntary Smoking) OR TS = (Cigarette Smoking))."

Inclusion and exclusion criteria {#section8-2050312117745223}
--------------------------------

Studies were included in systematic review and meta-analysis if they met the following criteria: (1) observational studies with a comparison (case-control and retrospective/prospective cohort studies). (2) Prevalence of smoking individuals in NAFLD patients and control group or Odds ratios are reported. (3) NAFLD patients were diagnosed by abdominal ultrasound or pathological report of liver biopsies. (4) The reported amount of cigarette smoking can be transformed to pack-year (Brinkman Index). The studies in which their NAFLD patients were under 18 years old and animal studies and non-available full-text articles were excluded. Other exclusion criteria were lacking information on cigarette smoking. Letter to editors, comments, position papers, unstructured papers, proceeding papers, thesis, and dissertation were also excluded. After checking for eligibility, the full text of qualified studies was obtained. The finally selected papers were read, tagged, and hand-noted by two reviewers (A.A.R.) and (M.T.N.) then verified by the second reviewer (K.A.R.). A brief flow diagram of the strategy is depicted in [Figure 1](#fig1-2050312117745223){ref-type="fig"}.

![Flow diagram of included and excluded studies.](10.1177_2050312117745223-fig1){#fig1-2050312117745223}

Search strategy development and study screening {#section9-2050312117745223}
-----------------------------------------------

After developing methods of study identification, source selection, and search combinations, two reviewers (A.A.R. and M.S.) performed the search for the literature. All search results were exported into the reference manager software, EndNote X7 (Thomson Reuters, New York, NY, USA). These studies were screened and compared to meet inclusion and exclusion criteria by two independent reviewers (A.A.R. and M.T.N.). Any disagreement was reconciled with the third reviewer (B.H.) who was also responsible for the supervision of the research.

Data extraction, quality assessment, and risk of bias assessment {#section10-2050312117745223}
----------------------------------------------------------------

Total of 1273 studies were identified and reviewed. Reference lists of all the final articles (20 articles) were hand-searched for any additional studies.

Quantitative papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using Newcastle--Ottawa Scale.^[@bibr21-2050312117745223]^ Methodological quality assessment using the newcastle ottawa scale (NOS) is based on the selection of study groups, comparability of study groups, and the ascertainment of the exposure/outcome of interest. Any discrepancy between two reviewers was evaluated by B.H.

NOS scores of 1--3, 4--6, and 7--10 show low-, intermediate-, and high-quality studies, respectively.^[@bibr4-2050312117745223]^ Also publication bias was assessed with funnel plot.

Primary data extraction form was designed and were used to extract data. Information was gathered for the following terms: author, publication year, keywords, country main results, confounder variables, study design, number of passive and active smokers, current and formers smokers, and light and heavy smokers. The main outcome measurement was the prevalence of smoking in patients with and without NAFLD.

Quality scores were assigned by two reviewers (A.A.R.) and (M.T.N.) and verified by K.A.R. The summary of our quality assessment approach has been outlined in [Table 1](#table1-2050312117745223){ref-type="table"}.

###### 

Quality assessment of the studies.

![](10.1177_2050312117745223-table1)

  Study                                             Selection   Comparability   Exposure   Total
  ------------------------------------------------- ----------- --------------- ---------- -------
  Chavez-Tapia et al.^[@bibr20-2050312117745223]^   5           1               3          9
  Caballería et al.^[@bibr22-2050312117745223]^     5           2               2          9
  Liu et al.^[@bibr23-2050312117745223]^            5           2               3          10
  Oniki et al.^[@bibr24-2050312117745223]^          4           2               2          8
  Hamabe et al.^[@bibr25-2050312117745223]^         5           2               2          9
  Zhang et al.^[@bibr26-2050312117745223]^          5           2               2          9
  Otgonsuren et al.^[@bibr27-2050312117745223]^     5           2               2          9
  Ozturk et al.^[@bibr28-2050312117745223]^         3           2               2          7
  Lin et al.^[@bibr29-2050312117745223]^            3           0               2          5
  Koch et al.^[@bibr30-2050312117745223]^           3           2               3          8
  Zhang et al.^[@bibr31-2050312117745223]^          4           2               3          9
  Singh et al.^[@bibr32-2050312117745223]^          4           2               2          8
  Koehler et al.^[@bibr33-2050312117745223]^        5           2               2          9
  Zhang et al.^[@bibr34-2050312117745223]^          1           2               2          5
  Zhang et al.^[@bibr26-2050312117745223]^          1           2               2          5
  Wu et al.^[@bibr35-2050312117745223]^             2           2               3          7
  Chang et al.^[@bibr36-2050312117745223]^          3           2               2          7
  Hung et al.^[@bibr37-2050312117745223]^           3           1               1          5
  Yang et al.^[@bibr38-2050312117745223]^           4           2               2          8
  Arslan et al.^[@bibr39-2050312117745223]^         3           2               2          7
  Total (mean)                                      73          36              44         153

Data synthesis {#section11-2050312117745223}
--------------

To assess the association, summary data from individual studies were pooled using a fixed effect model. All continuous data are summarized as odds ratio (OR) along with 95% confidence intervals (CIs). The inconsistency index (I2) was used to measure heterogeneity, with values of I2 \> 50% indicating substantial heterogeneity.40 All analyses were performed using comprehensive meta-analysis with a p-value \< 0.05 considered statistically significant.

Result {#section12-2050312117745223}
======

Characteristics of the studies {#section13-2050312117745223}
------------------------------

We initially identified a total of 1273 studies that met our search criteria. After performing a title and abstract review, 1135 studies were excluded, which resulted in 138 studies that underwent full-text review. Finally, 20 (9 cross-sectional, 6 case-control, 4 cohort, and 1 retrospective cohort) studies^[@bibr20-2050312117745223],[@bibr22-2050312117745223][@bibr23-2050312117745223][@bibr24-2050312117745223][@bibr25-2050312117745223][@bibr26-2050312117745223][@bibr27-2050312117745223][@bibr28-2050312117745223][@bibr29-2050312117745223][@bibr30-2050312117745223][@bibr31-2050312117745223][@bibr32-2050312117745223][@bibr33-2050312117745223][@bibr34-2050312117745223][@bibr35-2050312117745223][@bibr36-2050312117745223][@bibr37-2050312117745223][@bibr38-2050312117745223][@bibr39-2050312117745223][@bibr40-2050312117745223]--[@bibr41-2050312117745223]^ and 12 (7 cross-sectional, 3 case-control, and 2 cohort) studies^[@bibr20-2050312117745223],[@bibr22-2050312117745223],[@bibr23-2050312117745223],[@bibr24-2050312117745223],[@bibr27-2050312117745223],[@bibr28-2050312117745223],[@bibr30-2050312117745223],[@bibr32-2050312117745223],[@bibr33-2050312117745223],[@bibr35-2050312117745223],[@bibr39-2050312117745223],[@bibr41-2050312117745223]^ were included in the systematic review and meta-analysis, respectively. Characteristics of the studies included in this meta-analysis are described in [Table 2](#table2-2050312117745223){ref-type="table"}.

###### 

General information of the non-alcoholic fatty liver disease and control groups (n (%)).

![](10.1177_2050312117745223-table2)

  Author, publication year, country                                    Sample size   NAFLD, n (%)   Non-NAFLD, n (%)   Odds ratio   Confidence interval   Adjusting                                                 Diagnostic methods                                                                                                                                                                                                      Study design
  -------------------------------------------------------------------- ------------- -------------- ------------------ ------------ --------------------- --------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------
  Hamabe et al., 2011, Japan^[@bibr25-2050312117745223]^               1553                                                                               A, R, CC                                                  Abdominal ultrasonography                                                                                                                                                                                               Retrospective cohort
   Total smoker                                                                      93 (5.99)      216 (13.90)        2.683        (2.00--3.59)                                                                                                                                                                                                                                                                                            
   Light                                                                             24 (1.55)      57 (3.67)          0.94         (0.59--1.48)                                                                                                                                                                                                                                                                                            
   Heavy                                                                             69 (4.44)      159 (10.24)        2.7          (1.95--3.74)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        172 (11.1)     1072 (69)                                                                                                                                                                                                                                                                                                                               
  Liu et al., 2013, China^[@bibr23-2050312117745223]^                  2426                                                                               A, I, R, Z, AA, BB, CC, DD, EE, FF                        Ultrasonography                                                                                                                                                                                                         Cross-sectional
   Total smoker                                                                      420 (17.31)    962 (39.65)        1.047        (0.88--F1.25)                                                                                                                                                                                                                                                                                           
   Light                                                                             162 (6.67)     421 (17.35)        0.92         (1.39--1.30)                                                                                                                                                                                                                                                                                            
   Heavy                                                                             258 (10.63)    541 (22.30)        1.14         (3.98--7.98)                                                                                                                                                                                                                                                                                            
   Current                                                                           420 (17.31)    962 (39.65)        1.05         (0.87--1.25)                                                                                                                                                                                                                                                                                            
   Former                                                                            106 (4.36)     204 (8.40)         1.25         (0.95--1.63)                                                                                                                                                                                                                                                                                            
   Passive                                                                           5              70                 1.364                                                                                                                                                                                                                                                                                                                
   Non passive smokers                                                               4              225                                                                                                                                                                                                                                                                                                                                     
   Non-smoker                                                                        294 (12.12)    705 (29.06)                                                                                                                                                                                                                                                                                                                             
  Zhang et al., 2015, China^[@bibr26-2050312117745223]^                800                                                                                A, B, D, E, G, I, L, M, N, O, P, Q, T, U, W, Y            Ultrasonography                                                                                                                                                                                                         Case-control
   Total smoker                                                                      408 (51)       55 (6.87)          5.602        (3.93--7.98)                                                                                                                                                                                                                                                                                            
   Light                                                                             171 (21.38)    31 (3.87)          4.24         (2.68--6.46)                                                                                                                                                                                                                                                                                            
   Heavy                                                                             237 (29.63)    24 (3.00)          7.71         (4.66--11.95)                                                                                                                                                                                                                                                                                           
   Non-smoker                                                                        192 (24.00)    145 (18.13)                                                                                                                                                                                                                                                                                                                             
  Chavez-Tapia et al., 2006, Mexico^[@bibr20-2050312117745223]^        885                                                                                Not mention                                               Ultrasonography                                                                                                                                                                                                         Cross-sectional
   Total smoker                                                                      87 (9.83)      232 (26.21)        0.888        (0.66--1.21)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        168 (18.98)    398 (44.97)                                                                                                                                                                                                                                                                                                                             
  Caballería et al., 2010, Spain^[@bibr22-2050312117745223]^           766                                                                                A, E, G (male), S                                         Ultrasonography                                                                                                                                                                                                         Cross-sectional
   Total smoker                                                                      92(12.01)      250(32.63)         0.104        (0.80--1.53)                                                                                                                                                                                                                                                                                            
   Current                                                                           39(5.09)       150 (19.58)        0.78         (0.40--0.93)                                                                                                                                                                                                                                                                                            
   Former                                                                            53(6.91)       100 (13.05)        1.59         (0.83--1.87)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        106 (13.83)    318 (41.51)                                                                                                                                                                                                                                                                                                                             
  Oniki et al., 2013, Japan^[@bibr24-2050312117745223]^                696                                                                                A, G, B, EE, DD, R                                        Ultrasonography                                                                                                                                                                                                         Cross-sectional case-control
   Total smoker                                                                      61 (8.76)      221 (31.75)        1.38         (0.94--2.02)                                                                                                                                                                                                                                                                                            
   Current                                                                           21 (3.01)      57 (8.18)          1.84         (0.86--1.18)                                                                                                                                                                                                                                                                                            
   Former                                                                            40 (5.74)      164 (23.56)        1.22         (0.79--1.87                                                                                                                                                                                                                                                                                             
   Non-smoker                                                                        69 (9.91)      345 (49.56)                                                                                                                                                                                                                                                                                                                             
  Zatu et al., 2014, South Africa^[@bibr41-2050312117745223]^          195                                                                                A, G                                                      Not mentioned                                                                                                                                                                                                           Cross-sectional
   Total smoker                                                                      17             44                 0.629        (0.33--1.22)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        51             83                                                                                                                                                                                                                                                                                                                                      
  Zhang et al., 2015, China^[@bibr34-2050312117745223]^                1800                                                                               A, G, HH                                                  Based on guidelines for the diagnosis and treatment of NAFLD revised by the Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association in 2010^[@bibr42-2050312117745223]^            Case-control
   Total smoker                                                                      447 (49.67)    207 (23)           3.303        (2.70--4.05)                                                                                                                                                                                                                                                                                            
   Light                                                                             144 (16.00)    116 (12.89)        1.899        (1.37--2.55)                                                                                                                                                                                                                                                                                            
   Heavy                                                                             303 (33.67)    91 (10.11)         5.0937       (3.02--8.35)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        453 (50.33)    693 (77.00)                                                                                                                                                                                                                                                                                                                             
  Wu et al., 2015, China^[@bibr35-2050312117745223]^                   587                                                                                H, J, Q, X                                                Diagnosis of NAFLD was made according to criteria proposed by the fatty liver and alcoholic liver disease study group of the Chinese Liver Disease Association^[@bibr43-2050312117745223],[@bibr44-2050312117745223]^   Case-control
   Total smoker                                                                      129 (52.43)    124 (36.47)        1.275        (0.93--1.75)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        177 (49.57)    217 (63.53)                                                                                                                                                                                                                                                                                                                             
  Koehler et al., 2012, Netherland^[@bibr33-2050312117745223]^         2811                                                                               Not mention                                               Ultrasonography                                                                                                                                                                                                         cross-sectional
   Total smoker                                                                      660 (23.48)    1123 (40.00)       1.266        (1.08--1.49)                                                                                                                                                                                                                                                                                            
   Current                                                                           75 (2.67)      165 (2.31)                                                                                                                                                                                                                                                                                                                              
   Former                                                                            585 (20.81)    958 (34.08)                                                                                                                                                                                                                                                                                                                             
   Non-smoker                                                                        326 (11.60)    702 (24.97)                                                                                                                                                                                                                                                                                                                             
  Chang et al., 2013, Korea^[@bibr36-2050312117745223]^                43,166                                                                             G, AA, BB, HH                                             Abdominal ultrasonography                                                                                                                                                                                               Cohort
   Smoker                                                                            5133 (44)      8068 (25.6)        2.288        (2.19--2.39)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        6519 (56)      23,446 (74.4)                                                                                                                                                                                                                                                                                                                           
   Hung et al., 2013, Taiwan^[@bibr37-2050312117745223]^               521                                                                                                                                          B-mode ultrasonography                                                                                                                                                                                                  Cross-sectional
   Smoker                                                                            32 (12.3)      54 (20.8)          0.533        (0.33--0.86)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        229 (87.7)     206 (79.2)                                                                                                                                                                                                                                                                                                                              
  Yang et al., 2012, China^[@bibr38-2050312117745223]^                 903                                                                                A, B, G                                                   B-mode ultrasonography                                                                                                                                                                                                  Case-control
   Smoker                                                                            82 (19.2)      55 (11.8)          1.735        (1.20--2.51)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        354 (80.8)     412 (88.2)                                                                                                                                                                                                                                                                                                                              
  Arslan et al., 2014,Turkey^[@bibr39-2050312117745223]^               145                                                                                G, HH                                                     Based on biochemical, radiological, and histological criteria                                                                                                                                                           Cohort
   Smoker                                                                            29 (29)        20 (44.4)          0.511        (0.25--1.06)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        71 (71)        25 (55.6)                                                                                                                                                                                                                                                                                                                               
  Koch et al., 2015, Germany^[@bibr30-2050312117745223]^               354                                                                                A, G                                                      MRI                                                                                                                                                                                                                     Cohort
   Smoker                                                                            95 (50.8)      91 (54.5)          0.862        (0.57--1.31)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        92 (49.2)      76 (45.5)                                                                                                                                                                                                                                                                                                                               
  Singh et al., 2015, India^[@bibr32-2050312117745223]^                645                                                                                Not mentioned                                             Ultrasonography and histological confirmation whenever possible                                                                                                                                                         Case--Control
   Smoker                                                                            49 (10.6)      12 (6.6)           1.663        (0.86--3.20)                                                                                                                                                                                                                                                                                            
   Non-smoker                                                                        415 (89.4)     169 (93.4)                                                                                                                                                                                                                                                                                                                              
  Zhang et al., 2014, China^[@bibr31-2050312117745223]^                17,920                                                                             Confounding factors                                       Abdominal ultrasonography                                                                                                                                                                                               Prospective cohort
   Smoker                                                                            2178 (66.4)    11,716 (80)        0.494        (0.46--54)                                                                                                                                                                                                                                                                                              
   Non-smoker                                                                        1101 (33.6)    2925 (20)                                                                                                                                                                                                                                                                                                                               
  Otgonsuren et al., 2013, United States^[@bibr27-2050312117745223]^   10,565                                                                             A, G,L, EE, DD, II                                        Ultrasonography                                                                                                                                                                                                         Cross-sectional
   Total smoker                                                                      2241 (89.3)    7137 (88.6)        1.072        (0.93--1.24)                                                                                                                                                                                                                                                                                            
   Heavy/moderate smoker                                                             733 (29.2)     2658 (33)                                                                                                                                                                                                                                                                                                                               
   Light smoker                                                                      1508 (60.1)    4479 (55.6)                                                                                                                                                                                                                                                                                                                             
   Never smoker                                                                      269 (10.7)     918 (11.4)                                                                                                                                                                                                                                                                                                                              
  Lin et al., 2014, United States^[@bibr29-2050312117745223]^          304                                                                                A                                                         Abdominal ultrasonography                                                                                                                                                                                               Cross-sectional
   Smoking exposure                                                                  5 (55.6)       70 (23.7)          4.018        (1.05--15.07)                                                                                                                                                                                                                                                                                           
   No smoking exposure                                                               4 (44.4)       225 (76.3)                                                                                                                                                                                                                                                                                                                              
  Ozturk et al., 2016, Turkey^[@bibr28-2050312117745223]^              74                                                                                 A, B, C, D, E, F, I, K, L, M, O, P, X, Y, HH, MM,NN, OO   Liver biopsy                                                                                                                                                                                                            Cross-sectional
   Smoker                                                                            20 (27.03)     4 (5.40)           2.353        (0.69--8.03)                                                                                                                                                                                                                                                                                            
   Non-smokers                                                                       34 (45.45)     16 (21.62)                                                                                                                                                                                                                                                                                                                              

NAFLD: non-alcoholic fatty liver disease; MRI: magnetic resonance imaging.

A: age; B: body mass index; C: uric acid; D: aspartate transaminase; E: alanine transaminase; F: alkaline phosphatase; G: gender; H: high-density lipoprotein cholesterol; I: fasting serum insulin; J: white blood cell; K: glucose; L: waist circumference; M: hip circumference; N: waist-to-hip ratio; O: systolic blood pressure; P: diastolic blood pressure; Q: fasting blood glucose; R: dyslipidemia; S: metabolic syndrome; T: triglyceride; U: total cholesterol; W: low-density lipoprotein cholesterol; X: homeostatic model assessment (HOMA-IR); Y: high-sensitivity C-reactive protein; Z: education status; AA: alcohol consumption; BB: physical activity; CC: obesity; DD: hypertension; EE: diabetes; FF: use of anti-diabetic medication; HH: smoking status; II: race/ethnicity; MM: ferritin; NN: 2-h oral glucose tolerance test; OO: lipids.

Systematic review and meta-analysis studies that were included generated a total study population of 92,125 and 20,149 subjects, respectively. Among these, four studies^[@bibr22-2050312117745223][@bibr23-2050312117745223]--[@bibr24-2050312117745223],[@bibr33-2050312117745223]^ with 6699 subjects were included in the analysis for prevalence of former smoking, current smoking, and non-smoking among patients with and without NAFLD. "Former smoker" is defined as those who had not smoked in the 6 months leading to the study, while "current smoker" refers to those who had smoked in the 6 months prior to the study ([Table 3](#table3-2050312117745223){ref-type="table"}).The other two studies^[@bibr23-2050312117745223],[@bibr29-2050312117745223]^ with 2730 subjects were used for the analysis of the prevalence of passive smoking between patients with and without NAFLD ([Table 3](#table3-2050312117745223){ref-type="table"}).

###### 

Main results of the subgroups and total analysis included in this meta-analysis.

![](10.1177_2050312117745223-table3)

  Subgroup          Studies, n   Heterogeneity   Model of meta-analysis   Pooled OR (95% CI)   Z analysis             p-value                    
  ----------------- ------------ --------------- ------------------------ -------------------- ---------------------- ----------------- -------- -------
  Current smokers   4            49.618          0.114                    Fixed                1.034 (0.899--1.188)   0.465             0.642    
  Former smokers    4            0.00            0.768                    Fixed                1.316 (1.158--1.496)   4.211             0.001    
  Passive smokers   2            59.41           0.117                    Fixed                1.380 (1.199--1.588)   4.503             0.001    
  Light smoker      3            20.924          0.282                    Fixed                1.074 (0.991--1.332)   1.262             0.207    
  Heavy smoker      2            54.98           0.136                    Fixed                1.014 (0.895--1.149)   0.219             0.826    
  Study design      Cohort       2               10.81                    0.29                 Fixed                  2.97 (2.2--2.4)   37.066   0.001
  Case-control      4            0.00            0.622                    Fixed                1.451 (1.94--1.762)    3.748             0.001    
  Cross-sectional   9            43.83           0.001                    Fixed                1.113 (1.025--1.208)   2.545             0.011    
  Total             12           40.012          0.074                    Fixed                1.110 (1.029--1.199)   2.672             0.008    

OR: odds ratio; CI: confidence interval.

Meta-analysis results {#section14-2050312117745223}
---------------------

Among 20 studies, 12 observational studies involving 20,149 people were included in the data analysis with cumulative meta-analysis. There was a significant association between Smoking and NAFLD with pooled OR of 1.110 (95% CI, 1.028--1.199), p value = 0.008. The statistical heterogeneity was medium with I2 of 40.012%, p heterogeneity = 0.074 ([Figure 2](#fig2-2050312117745223){ref-type="fig"}) and funnel plot show publication bias in study ([Figure 3](#fig3-2050312117745223){ref-type="fig"}).

![(a) Forest plot of the included studies assessing the association between smoking and non-alcoholic fatty liver disease; a diamond data marker represents the overall OR, 95% CI, and relative weight for the outcome of interest. (b) Funnel plot of the included studies represents the tau score = −0.075, z-value for tau = 0.34, and p-value (two-tailed) = 0.73 in Begg and Mazumdar rank correlation test that show publication bias does not exist in this study.](10.1177_2050312117745223-fig2){#fig2-2050312117745223}

![Subgroup analysis assessing (a) current and (b) former smokers for the risk of non-alcoholic fatty liver disease in included studies; a diamond data marker represents the overall OR and 95% CI for the outcome of interest.](10.1177_2050312117745223-fig3){#fig3-2050312117745223}

Subgroup analysis {#section15-2050312117745223}
-----------------

Classification of smoking varies between studies, which may impact the overall estimates. We, therefore, stratified the risk of NAFLD based on the study's classification of smoking. Four studies classify smoking into a current subgroup and a former subgroup.^[@bibr22-2050312117745223][@bibr23-2050312117745223]--[@bibr24-2050312117745223],[@bibr33-2050312117745223]^ There was a significant association between former smoking and NAFLD with pooled OR of 1.316 (95% CI, 1.158--1.496; I2 = 0.001; p-heterogeneity = 0.007), p-value = 0.768. However, in the current subgroup, no significant association between smoking and NAFLD was observed (pooled OR 1.034; 95% CI, 0.899--1.188; I2 = 49.618; p-heterogeneity = 0.114), p-value = 0.642 ([Figure 3](#fig3-2050312117745223){ref-type="fig"}). Also, a subgroup analysis for passive smokers was performed including two studies^[@bibr23-2050312117745223],[@bibr29-2050312117745223]^ yielding a significant relation between NAFLD and passive smoking with a pooled OR of 1.380 (95% CI, 1.199--1.588; p-value = 0.001; I2 = 59.41; p-heterogeneity = 0.117) ([Figures 4](#fig4-2050312117745223){ref-type="fig"}). Also, an analysis was performed according to study design (cross-sectional studies, case-control studies, and cohort studies) for the risk of non-alcoholic fatty liver disease in included studies ([Figure 5](#fig5-2050312117745223){ref-type="fig"}).

![Subgroup analysis assessing passive smokers for the risk of non-alcoholic fatty liver disease in included studies; a diamond data marker represents the overall OR and 95% CI for the outcome of interest.](10.1177_2050312117745223-fig4){#fig4-2050312117745223}

![Analysis assessing according to study design ((a) cross-sectional studies, (b) case-control studies, and (c) cohort studies) for the risk of non-alcoholic fatty liver disease in included studies; a diamond data marker represents the overall OR and 95% CI for the outcome of interest.](10.1177_2050312117745223-fig5){#fig5-2050312117745223}

Discussion {#section16-2050312117745223}
==========

There are controversial data on the association between smoking and NAFLD. In this study, we systematically reviewed 20 studies and meta-analyzed 12 studies, to further evaluate the association. Although our results supported a putative relationship between NAFLD and smoking, exhibiting a stronger relation in cohort studies (OR = 2.97) and in case-control studies (OR = 1.451), there was no significant association between smoking and NAFLD in current smokers. However, this association was considerable in former smokers. In addition, in passive smokers, NAFLD and smoking showed a significant relation.

Several studies demonstrated different conclusions about the association between smoking and NAFLD. Liu et al.^[@bibr23-2050312117745223]^ observed a positive association between heavy active smoking and NAFLD in the Chinese population. These results may be due to the fast deposition of fat in the liver after using tobacco. Besides, although higher Brinkman Index is associated with NAFLD, cessation of smoking may lead to NAFLD by increasing BMI.^[@bibr22-2050312117745223]^ As a result, a clear history of previous smoking habits is crucial to prevent NAFLD development.

Another possible mechanism that may play a role in sex-related NAFLD is the possible influence of sex hormones on smoking-induced NAFLD.^[@bibr45-2050312117745223],[@bibr46-2050312117745223]^ The amount of body fat can change as a result of smoking cigarettes due to the anti-estrogenic properties of cigarette smoke, which could potentially explain the independent role of BMI in the association between active smoking and NAFLD.^[@bibr47-2050312117745223][@bibr48-2050312117745223]--[@bibr49-2050312117745223]^

Glucose oxidative metabolism can be induced by long-term smoking, which causes the inhibition of the non-oxidative reactions and ultimately leads to higher levels of plasma free fatty acid (FFA). Hepatocytes and adipose tissue absorb these FFAs and turn them into triglycerides causing insulin resistance (IR).^[@bibr26-2050312117745223]^ IR frequently occurs in patients with NAFLD and mostly results from deposition of fat, FFAs production in skeletal muscle, decreased glucose absorption, and suppressed gluconeogenesis in liver cells.^[@bibr50-2050312117745223]^

A study^[@bibr20-2050312117745223]^ did not find any association between smoking, smoking intensity (number of packs/year), and the prevalence of NAFLD. However, univariate regression analysis showed that NAFLD and smoking were not associated with each other.^[@bibr20-2050312117745223]^ In these studies, the samples were very similar, and the primary variable of these studies (smoking) did not influence the prevalence of NAFLD. Limitations of these studies should be considered, which could explain the absence of an association between smoking and NAFLD. First, the studies did not evaluate IR, which can partially affect the results. The other factor that helps explain this discrepancy is the fact that physical activity was not evaluated in these studies, which is another factor related to IR and can possibly be affected by smoking.^[@bibr20-2050312117745223]^

In our study, current smoking did not have any association with NAFLD. A possible explanation for this finding could be unknown confounding factors (period of smoking, amount of smoking, etc.) which were not considered. Another explanation is that because NAFLD is a chronic liver disease; having a history of smoking for a period of time could be a risk factor for NAFLD. An increase in body weight and BMI as a consequence of cessation of smoking may be another explanation for the development of NAFLD in former smokers.

In this study, we discovered that passive smoking has a significant relation with NAFLD. We also found that passive smoking increases the risk of NAFLD about 1.38-fold. However, the effects of smoking cigarettes on active smokers (current smoker, former smoker, and total smoker) are less than passive smokers. This result may be due to a factor which is discussed in a study which showed side stream smoke has higher concentration of harmful chemicals than mainstream smoke.^[@bibr51-2050312117745223]^ A study performed by Liu et al.^[@bibr23-2050312117745223]^ demonstrated that passive smokers have more liver steatosis than light and moderate active smokers. Further study is needed to compare the effects of passive and active smoking on NAFLD.^[@bibr29-2050312117745223]^

This systematic review has several limitations. First, the included studies were all case-control, cross-sectional, or cohort studies using questionnaires to evaluate smoking habits in participants, so our results are based on self-reported data until laboratory and clinical data are collected. Second, some studies only investigated the association between smoking and NAFLD in male participants. Several of our studies diagnosed NAFLD based on ultrasonography without the requirement for a pathologic confirmation after liver biopsy. Some factors such as physical activity, diet, caffeine consumption, or socioeconomic factors may play the role of confounders; however, more studies were needed to determine the exact place of smoking in NAFLD; nevertheless in this study, these confounder variables were not included. The inclusion of over 92,125 patients was a significant strength of this meta-analysis. While cross-sectional, case-controlled, and cohort studies have their inherent limitations, with the utilization of 12 studies in meta-analysis, we were able to generate a much greater statistical power compared with a single study.

In conclusion, our results show that smoking is significantly associated with NAFLD. While we concluded that there was an association between smoking and NAFLD in former smokers, there was not any correlation in current smokers.

For clinicians, it is obvious that smoking is correlated with NAFLD, which is one of the most common chronic liver diseases. Physicians should warn their patients based on the potential effects of smoking on the pathogenesis and progression of NAFLD and the high prevalence of smoking in different populations. This study enables researchers to investigate the mechanisms of smoking-related NAFLD and run cohort studies considering confounders such as physical activity, diet, and socioeconomic factors.

**Declaration of conflicting interests:** The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

**Ethical approval:** Ethical approval for this study was obtained from Mashhad University of Medical Science.

**Funding:** The author(s) received the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Research Council of Mashhad University of Medical Science, Dr Azita Ganji and Gastrology and Enterology Research Center, Emam Reza Hospital of Mashhad.
